| Application no. and date | 02741849.0 (espacenet) (Federated) (European Patent Register), 20020605 | | Patent/reg. no. and date | DK/EP 1406656, 20130109 | | Publication date | 20040414 | | Priority no. and date | US 296961 P, 20010608 | | EP pub. no. and date |
EP 1406656 20040414 | | Effective date | | | Applicant/owner | AbbVie Biotechnology Ltd, Harbour Fiduciary Services Limited
Thistle House
4 Burnaby Street
Hamilton Pembroke HM 11 , BM | | Applicant ref. no. | P011111EPDK1 EJ/GB | | Inventor | KEMPENI, Joachim, 75 Gimmeldinger Street
67433 Neustadt, DE,
WEISS, Roberta, 936 Clover Hill Road
Wynnewood, PA 19096, US,
FISCHKOFF, Steven, A., 5 Canoe Brook Road
Short Hills, NJ 07078, US | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 19/02 (2006.01) , A61P 37/06 (2006.01) , C07K 16/24 (2006.01) , A61K 31/519 (2006.01) | | Title | Fremgangsmåder til administrering af anti-TNF-alfa-antistoffer | | Int. application no. | US2002017790 | | Int. publication no. | WO2002100330 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
